Intravenous Immunoglobulin for Heparin-Induced Thrombocytopenia.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

1. Autoimmune Heparin-Induced Thrombocytopenia.Journal of clinical medicine · 2023
   Review
2. Cardiac surgery in acute heparin-induced thrombocytopenia managed with therapeutic plasma exchange and intravenous immunoglobulin.Research and practice in thrombosis and haemostasis · 2023
   Article
3. Bivalirudin as a Systemic Anticoagulant and Flush Solution Additive for Sequential Mitral and Tricuspid Valve Percutaneous Edge-to-Edge Repair in a Patient With Heparin-Induced Thrombocytopenia.Journal of cardiothoracic and vascular anesthesia · 2022
   Article
4. Use of IV Immunoglobulin G in Heparin-Induced Thrombocytopenia Patients Is Not Associated With Increased Rates of Thrombosis: A Population-Based Study.Chest · 2020
   Article
5. Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia.Transfusion · 2019
   Article
6. Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia.Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2018
   Review
7. HITs and misses in 100 years of heparin.Hematology. American Society of Hematology. Education Program · 2017
   Review

Corrections and comments

• Comment on
  IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia.2017

Authors and funding

2 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as